Fonar EBITDA Margin 2010-2025 | FONR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fonar (FONR) over the last 10 years. The current EBITDA margin for Fonar as of March 31, 2025 is .
| Fonar EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.10B | $0.02B | 21.36% |
| 2024-12-31 | $0.10B | $0.02B | 21.57% |
| 2024-09-30 | $0.10B | $0.02B | 23.53% |
| 2024-06-30 | $0.10B | $0.03B | 25.24% |
| 2024-03-31 | $0.10B | $0.02B | 23.30% |
| 2023-12-31 | $0.10B | $0.03B | 24.51% |
| 2023-09-30 | $0.10B | $0.03B | 26.73% |
| 2023-06-30 | $0.10B | $0.02B | 24.49% |
| 2023-03-31 | $0.10B | $0.03B | 25.77% |
| 2022-12-31 | $0.10B | $0.03B | 27.84% |
| 2022-09-30 | $0.10B | $0.03B | 29.90% |
| 2022-06-30 | $0.10B | $0.03B | 31.63% |
| 2022-03-31 | $0.10B | $0.03B | 30.61% |
| 2021-12-31 | $0.10B | $0.03B | 28.13% |
| 2021-09-30 | $0.09B | $0.03B | 26.88% |
| 2021-06-30 | $0.09B | $0.02B | 25.56% |
| 2021-03-31 | $0.09B | $0.02B | 20.93% |
| 2020-12-31 | $0.09B | $0.02B | 20.00% |
| 2020-09-30 | $0.09B | $0.02B | 20.00% |
| 2020-06-30 | $0.09B | $0.02B | 20.93% |
| 2020-03-31 | $0.09B | $0.02B | 26.44% |
| 2019-12-31 | $0.09B | $0.03B | 30.68% |
| 2019-09-30 | $0.09B | $0.03B | 30.68% |
| 2019-06-30 | $0.09B | $0.03B | 29.89% |
| 2019-03-31 | $0.09B | $0.03B | 31.40% |
| 2018-12-31 | $0.08B | $0.02B | 28.57% |
| 2018-09-30 | $0.08B | $0.02B | 28.92% |
| 2018-06-30 | $0.08B | $0.02B | 29.63% |
| 2018-03-31 | $0.08B | $0.02B | 28.40% |
| 2017-12-31 | $0.08B | $0.03B | 31.25% |
| 2017-09-30 | $0.08B | $0.02B | 29.49% |
| 2017-06-30 | $0.08B | $0.02B | 29.49% |
| 2017-03-31 | $0.08B | $0.02B | 27.63% |
| 2016-12-31 | $0.08B | $0.02B | 25.33% |
| 2016-09-30 | $0.08B | $0.02B | 25.33% |
| 2016-06-30 | $0.07B | $0.02B | 22.97% |
| 2016-03-31 | $0.07B | $0.02B | 25.00% |
| 2015-12-31 | $0.07B | $0.02B | 24.29% |
| 2015-09-30 | $0.07B | $0.02B | 23.19% |
| 2015-06-30 | $0.07B | $0.02B | 23.19% |
| 2015-03-31 | $0.07B | $0.02B | 23.19% |
| 2014-12-31 | $0.07B | $0.02B | 21.74% |
| 2014-09-30 | $0.07B | $0.02B | 21.43% |
| 2014-06-30 | $0.07B | $0.02B | 23.19% |
| 2014-03-31 | $0.07B | $0.02B | 21.43% |
| 2013-12-31 | $0.07B | $0.01B | 21.54% |
| 2013-09-30 | $0.06B | $0.01B | 21.05% |
| 2013-06-30 | $0.05B | $0.01B | 18.00% |
| 2013-03-31 | $0.04B | $0.01B | 20.93% |
| 2012-12-31 | $0.04B | $0.01B | 21.95% |
| 2012-09-30 | $0.04B | $0.01B | 22.50% |
| 2012-06-30 | $0.04B | $0.01B | 22.50% |
| 2012-03-31 | $0.04B | $0.01B | 18.92% |
| 2011-12-31 | $0.04B | $0.01B | 19.44% |
| 2011-09-30 | $0.04B | $0.01B | 20.00% |
| 2011-06-30 | $0.03B | $0.01B | 17.65% |
| 2011-03-31 | $0.04B | $0.01B | 14.29% |
| 2010-12-31 | $0.03B | $0.00B | 8.82% |
| 2010-09-30 | $0.03B | 0 | 0.00% |
| 2010-06-30 | $0.03B | $0.00B | -6.25% |
| 2010-03-31 | $0.03B | $0.00B | -6.06% |
| 2009-12-31 | $0.04B | $0.00B | -2.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.087B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.146B | 27.67 |
| Boston Scientific (BSX) | United States | $150.504B | 37.68 |
| Stryker (SYK) | United States | $142.511B | 29.80 |
| EssilorLuxottica (ESLOY) | France | $130.598B | 0.00 |
| Medtronic (MDT) | Ireland | $110.517B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.287B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.240B | 26.92 |
| ResMed (RMD) | United States | $36.670B | 27.54 |
| Agilent Technologies (A) | United States | $32.977B | 21.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.574B | 15.47 |
| Terumo (TRUMY) | Japan | $26.206B | 34.04 |
| Insulet (PODD) | United States | $21.421B | 84.09 |
| Koninklijke Philips (PHG) | Netherlands | $20.782B | 14.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.848B | 11.46 |
| Baxter (BAX) | United States | $15.354B | 11.46 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.271B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $5.391B | 13.60 |
| Prestige Consumer Healthcare (PBH) | United States | $4.135B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.612B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.315B | 15.10 |
| ICU Medical (ICUI) | United States | $3.199B | 23.59 |
| Envista Holdings (NVST) | United States | $3.124B | 25.96 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.614B | 0.00 |
| Acuren (TIC) | United States | $1.361B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.66 |
| Neogen (NEOG) | United States | $1.146B | 14.67 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.57 |
| BioLife Solutions (BLFS) | United States | $1.033B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.845B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.774B | 0.00 |
| CeriBell (CBLL) | United States | $0.641B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Owens & Minor (OMI) | United States | $0.583B | 4.83 |
| Capricor Therapeutics (CAPR) | United States | $0.557B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.532B | 0.00 |
| Valneva SE (VALN) | France | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.331B | 58.80 |
| VAREX IMAGING (VREX) | United States | $0.320B | 11.77 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.233B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 54.95 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.28 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.72 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| United-Guardian (UG) | United States | $0.038B | 12.97 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |